NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00061776 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

NeurogesX